| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| V Popovic, S Damjanovic, D Micic, M Petakov, C Dieguez, F F Casanuev. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6. The Journal of clinical endocrinology and metabolism. vol 79. issue 2. 1994-09-01. PMID:8045963. |
growth hormone (gh) secretion in active acromegaly after the combined administration of gh-releasing hormone and gh-releasing peptide-6. |
1994-09-01 |
2023-08-12 |
human |
| A Colao, B Merola, D Ferone, M R Calabrese, S Longobardi, R Spaziante, G Di Renzo, L Annunziato, G Lombard. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies. European journal of endocrinology. vol 131. issue 1. 1994-08-22. PMID:8038903. |
the ability of crh to cause a paradoxical response of gh in acromegaly is still under debate. |
1994-08-22 |
2023-08-12 |
Not clear |
| A Colao, B Merola, D Ferone, M R Calabrese, S Longobardi, R Spaziante, G Di Renzo, L Annunziato, G Lombard. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies. European journal of endocrinology. vol 131. issue 1. 1994-08-22. PMID:8038903. |
in this study, the effect of crh administration on gh release was evaluated in a large series of patients with active acromegaly, both in vivo, compared to that of trh and gnrh, and in vitro. |
1994-08-22 |
2023-08-12 |
Not clear |
| A Giustina, A R Bussi, M Doga, W B Wehrenber. Effect of hydrocortisone on the growth hormone response to growth hormone-releasing hormone in acromegaly. Hormone research. vol 41. issue 1. 1994-07-22. PMID:8013941. |
our recent data show that acute and sustained hypercortisolism decreases circulating growth hormone (gh) levels in acromegaly with respect to saline infusion. |
1994-07-22 |
2023-08-12 |
human |
| A Giustina, A R Bussi, M Doga, W B Wehrenber. Effect of hydrocortisone on the growth hormone response to growth hormone-releasing hormone in acromegaly. Hormone research. vol 41. issue 1. 1994-07-22. PMID:8013941. |
the aim of our study was to investigate the acute effects of an intravenous infusion of hydrocortisone on the gh response to growth hormone-releasing hormone (ghrh) in acromegaly. |
1994-07-22 |
2023-08-12 |
human |
| P J Ho, C A Jaffe, R D Friberg, W F Chandler, A L Barka. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors. The Journal of clinical endocrinology and metabolism. vol 78. issue 6. 1994-07-05. PMID:7911124. |
gh concentration profiles in patients with acromegaly are characterized by rapid gh pulsatility and high interpulse gh concentrations. |
1994-07-05 |
2023-08-12 |
human |
| P J Ho, C A Jaffe, R D Friberg, W F Chandler, A L Barka. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors. The Journal of clinical endocrinology and metabolism. vol 78. issue 6. 1994-07-05. PMID:7911124. |
thus, the pattern of gh secretion in acromegaly may conceivably be attributed to high ghrh pulse frequency and/or srih deficiency. |
1994-07-05 |
2023-08-12 |
human |
| P J Ho, C A Jaffe, R D Friberg, W F Chandler, A L Barka. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors. The Journal of clinical endocrinology and metabolism. vol 78. issue 6. 1994-07-05. PMID:7911124. |
we have studied pulsatile gh secretion in 12 patients with acromegaly before and after apparently complete removal of their pituitary tumors. |
1994-07-05 |
2023-08-12 |
human |
| P J Ho, C A Jaffe, R D Friberg, W F Chandler, A L Barka. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors. The Journal of clinical endocrinology and metabolism. vol 78. issue 6. 1994-07-05. PMID:7911124. |
thus, srih secretion in acromegaly is not inherently deficient, and high interpulse gh levels reflect the mass of tumorous somatotrophs. |
1994-07-05 |
2023-08-12 |
human |
| P J Ho, C A Jaffe, R D Friberg, W F Chandler, A L Barka. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors. The Journal of clinical endocrinology and metabolism. vol 78. issue 6. 1994-07-05. PMID:7911124. |
the persistence of rapid gh pulsatility in apparently "cured" patients with acromegaly suggests that abnormally rapid ghrh pulsatility may be an inherent component of the disease process. |
1994-07-05 |
2023-08-12 |
human |
| C A Jaffe, A L Barka. Acromegaly. Recognition and treatment. Drugs. vol 47. issue 3. 1994-06-24. PMID:7514973. |
acromegaly is a chronic debilitating disease caused by growth hormone (gh) hypersecretion, usually from a pituitary adenoma. |
1994-06-24 |
2023-08-12 |
Not clear |
| V Macchia, A Marian. [Laboratory diagnosis of growth hormone]. Minerva endocrinologica. vol 18. issue 3 Suppl 1. 1994-06-23. PMID:7910655. |
as it concerns increase gh secretion the diagnosis is clinically made (acromegaly and gigantism) and the laboratory has only the role to confirm it by the assessment of basal and stimulated gh secretion. |
1994-06-23 |
2023-08-12 |
Not clear |
| T Svoboda, H Kotzmann, M Clodi, P Bernecker, G Geyer, A Luge. The non ergot D2-dopamine agonist CV 205-502 decreases growth hormone concentrations in acromegalic patients. Endocrine research. vol 20. issue 1. 1994-06-02. PMID:7909510. |
it was the aim of this study to test for a possible effect of the new non ergot dopamine agonist cv 205-502 on plasma growth hormone (gh) concentrations in acromegaly. |
1994-06-02 |
2023-08-12 |
Not clear |
| T Svoboda, H Kotzmann, M Clodi, P Bernecker, G Geyer, A Luge. The non ergot D2-dopamine agonist CV 205-502 decreases growth hormone concentrations in acromegalic patients. Endocrine research. vol 20. issue 1. 1994-06-02. PMID:7909510. |
we conclude that acute administration of cv 205-502 suppresses gh secretion in acromegalic patients and thus could serve as an alternative therapy in acromegaly. |
1994-06-02 |
2023-08-12 |
Not clear |
| M R Johnson, H S Chowdrey, F Thomas, C Grint, S L Lightma. Pharmacokinetics and efficacy of the long-acting somatostatin analogue somatuline in acromegaly. European journal of endocrinology. vol 130. issue 3. 1994-05-19. PMID:7908838. |
fifteen patients with active acromegaly, as defined by random growth hormone (gh) levels greater than 10 mu/l, which fail to be suppressed to less than 5 mu/l following an oral glucose load, were studied. |
1994-05-19 |
2023-08-12 |
Not clear |
| L De Marinis, A Mancini, P Zuppi, C Fiumara, T Iacona, G Conte, M L Fabrizi, D Valle, C Anile, G Mair. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations]. Minerva chirurgica. vol 48. issue 21-22. 1994-05-12. PMID:8152567. |
we have evaluated the paradoxical gh response to 1-dopa in acromegaly, in order to clarify the relationships between this datum and the tumour size, the basal gh secretion, the gh response to trh and the long-term prognosis. |
1994-05-12 |
2023-08-12 |
human |
| K S Lam, R W Pang, E D Janus, A W Kung, C C Wan. Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly. Atherosclerosis. vol 104. issue 1-2. 1994-04-28. PMID:8141841. |
we investigated the relationship between serum apolipoprotein(a) (apo(a)) and growth hormone (gh) levels in 15 patients with acromegaly before and during treatment with octreotide, a long-acting somatostatin analogue, 288-600 micrograms/day s.c., for 6 months. |
1994-04-28 |
2023-08-12 |
Not clear |
| K S Lam, R W Pang, E D Janus, A W Kung, C C Wan. Serum apolipoprotein(a) correlates with growth hormone levels in Chinese patients with acromegaly. Atherosclerosis. vol 104. issue 1-2. 1994-04-28. PMID:8141841. |
our findings suggest that apo(a) may constitute another cardiovascular risk factor in untreated acromegaly and that gh may be involved in the regulation of circulating apo(a) concentration. |
1994-04-28 |
2023-08-12 |
Not clear |
| M Losa, M Arosio, A Cusin, O Biella, E Palmieri, G Faglia, M Giovanell. Acute effects of a single administration of dexamethasone on basal and growth hormone-releasing hormone stimulated GH secretion in acromegaly. Clinical endocrinology. vol 40. issue 2. 1994-04-25. PMID:8137516. |
acute effects of a single administration of dexamethasone on basal and growth hormone-releasing hormone stimulated gh secretion in acromegaly. |
1994-04-25 |
2023-08-12 |
human |
| K Hanew, A Utsumi, A Sugawara, Y Shimizu, K Ab. Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly. The Journal of clinical endocrinology and metabolism. vol 78. issue 3. 1994-04-12. PMID:8126120. |
enhanced gh responses to combined administration of ghrp and ghrh in patients with acromegaly. |
1994-04-12 |
2023-08-12 |
Not clear |